Lars Fruergaard Jorgensen
Chief Executive Officer chez NOVO NORDISK A/S
Provenance du réseau au premier degré de Lars Fruergaard Jorgensen
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
131
| Public Company | Pharmaceuticals: Major | 131 |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.
28
| Non-Profit Organization | Miscellaneous Commercial Services | 28 |
University of Aarhus
20
| College/University | Other Consumer Services | 20 |
19
| Public Company | Information Technology Services | 19 |
| Public Company | Pharmaceuticals: Major | 15 | |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
15
| Extinct | Pharmaceuticals: Major | 15 |
Harno Invest A/S
 Harno Invest A/S Financial ConglomeratesFinance Harno Invest A/S provides investment and financial services. The company was founded in 2002 and is located in Copenhagen, Denmark
6
| Subsidiary | Financial Conglomerates | 6 |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom.
5
| Subsidiary | Medical/Nursing Services | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Lars Fruergaard Jorgensen via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Administrative Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer General Counsel Sales & Marketing Chief Executive Officer | |
| INTERNATIONAL FLAVORS & FRAGRANCES INC. | Food: Specialty/Candy | Director/Board Member Chief Executive Officer Chief Executive Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Medarex, Inc.
 Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | Miscellaneous Commercial Services | President Director/Board Member Director/Board Member Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| SANOFI | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
International Federation of Pharmaceutical Manufacturers
 International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Biotechnology | Director/Board Member Corporate Officer/Principal President | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member President | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
| UCB | Pharmaceuticals: Major | Chairman Chief Executive Officer Corporate Officer/Principal | |
| AP MOLLER MAERSK | Marine Shipping | Chairman Corporate Officer/Principal Director of Finance/CFO | |
| GN STORE NORD A/S | Telecommunications Equipment | Director/Board Member Corporate Officer/Principal Public Communications Contact | |
Rambøll Gruppen A/S
 Rambøll Gruppen A/S Engineering & ConstructionIndustrial Services Rambøll Gruppen A/S provides engineering, design, and consultancy services. It offers services in the areas of buildings, transportation, water, environment and health, energy, oil and gas, telecom, planning and urban design, and management consulting. The company was founded by Børge Johannes Rambøll and Johan Georg Hannemann on October 15, 1945 and is headquartered in Copenhagen, Denmark. | Engineering & Construction | Director/Board Member Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | President Chief Executive Officer Public Communications Contact Chief Executive Officer Director/Board Member Chief Executive Officer | |
| SCANDINAVIAN INVESTMENT GROUP A/S | Real Estate Investment Trusts | Chairman Director/Board Member | |
Maersk A/S
 Maersk A/S Marine ShippingTransportation Maersk A/S engages in the wholesale of solid, liquid, and gaseous fuels. It purchases and sells bunkers and lubricant. The company was founded on October 25, 1962 and is headquartered in Copenhagen, Denmark. | Marine Shipping | Director/Board Member President | |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Director/Board Member Director/Board Member Sales & Marketing | |
| INSEAD | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin | |
| Copenhagen Business School | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Sales & Marketing Chairman Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Graduate Degree Chairman Graduate Degree Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
| University of Aalborg | College/University | Graduate Degree Graduate Degree | |
| École des Hautes Études Commerciales de Paris | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Masters Business Admin | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Chairman | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO President Director of Finance/CFO President Director/Board Member | |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Biotechnology | Director/Board Member Director/Board Member | |
| Danmark-Amerika Fondet | Chairman Director/Board Member Director/Board Member | ||
| ADOCIA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novo Nordisk Region Europe A/S
 Novo Nordisk Region Europe A/S Financial ConglomeratesFinance Novo Nordisk Region Europe A/S holds ownership interests in other companies to undertake investment and financing activities. It offers service on an operational basis, including the placement of capital in companies and real estate. The company was founded September 14, 2001 and is headquartered in Bagsvaerd, Denmark. | Financial Conglomerates | Chairman Chairman Director/Board Member | |
| Steno Diabetes Center A/S | Director/Board Member Chairman Chairman | ||
Novo Nordisk Health Care AG
 Novo Nordisk Health Care AG Pharmaceuticals: MajorHealth Technology Novo Nordisk Health Care AG engages in the production and distribution of chemical and pharmaceutical products as well as articles for diagnostic and therapeutic applications. It also specializes in the research in and development of products, therapeutic methods, and display techniques primarily used in the chemical, pharmaceutical, and diagnostic fields. The company was founded on August 10, 2000 and is headquartered in Zurich, Switzerland. | Pharmaceuticals: Major | Chairman Chief Executive Officer Director/Board Member | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Director/Board Member Chief Executive Officer | |
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Director/Board Member Director/Board Member |
Statistiques
Internationale
| Danemark | 25 |
| Etats-Unis | 15 |
| Suisse | 6 |
| France | 5 |
| Royaume-Uni | 2 |
Sectorielle
| Health Technology | 23 |
| Consumer Services | 8 |
| Finance | 6 |
| Commercial Services | 4 |
| Consumer Non-Durables | 3 |
Opérationnelle
| Director/Board Member | 624 |
| Chairman | 235 |
| Corporate Officer/Principal | 214 |
| Independent Dir/Board Member | 145 |
| Chief Executive Officer | 119 |
Relations les plus connectées
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Anne Broeng | 47 |
| Göran Albert Ando | 44 |
| Henrik Poulsen | 37 |
| Marie-Laure Jeanne Antoinette Pochon | 36 |
| Marc M. P. de Garidel | 31 |
| Sten Scheibye | 31 |
| Harry H. Penner | 31 |
| Ian Read | 29 |
| Martin MacKay | 28 |
| Thomas Paul Koestler | 26 |
| Bruce Carter | 25 |
| Douglas Williams | 25 |
| Sylvie Grégoire | 25 |
| Jesper Brandgaard | 25 |
- Bourse
- Insiders
- Lars Fruergaard Jorgensen
- Connexions Sociétés
